Press "Enter" to skip to content

New patent for Janssen Prods drug SYMTUZA

3
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Prods drug SYMTUZA

Annual Drug Patent Expirations for SYMTUZA
Annual Drug Patent Expirations for SYMTUZA

Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.

SYMTUZA drug price trends.

Drug patent litigation for SYMTUZA.

This drug has five hundred and seventy-nine patent family members in fifty-nine countries.

The generic ingredient in SYMTUZA is cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate. One supplier is listed for this compound. Additional details are available on the cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Prods drug SYMTUZA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions